Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
40 participants
INTERVENTIONAL
2024-06-30
2025-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients' Grouping:
The patients will be randomly divided into two equal uniform groups each consists of 20 patients:
Group A:
20 patients with non-restorable mandibular molar tooth will be treated with an immediately placed dental implant in conjunction with a dentin-derived membrane from the extracted tooth.
Group B:
20 patients with non-restorable mandibular molar tooth will be treated with an immediately placed dental implant in conjunction with extended platelet rich fibrin membrane.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Peri-Implant Tissues of Different Implant Assisted Overdentures
NCT06647199
Immediate Implant With Different Filling Materials
NCT05878392
Immediate Implant Placement With Different Materials of Customized Healing Abutment for Guiding Peri-implant Soft Tissue Healing in Posterior Teeth
NCT06645444
Immediate Loading of Four Single Piece Compressive Implants for Bar Retained Mandibular Overdenture
NCT06514391
Pre-extractive Inter-radicular Implant Bed Preparation Versus Conventional Post-extractive Inter-radicular Implant Bed Preparation in Mandibular Molars
NCT03640091
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
immediate implant with dentin-derived membrane
immediate implant placement with dentin-derived membrane
immediate implant placement with dentin-derived membrane and allograft in mandibular molar area
immediate implant with extended platelet rich fibrin membrane
immediate implant with extended platelet rich fibrin membrane
immediate implant with extended platelet rich fibrin membrane and allograft in mandibular molar area
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
immediate implant placement with dentin-derived membrane
immediate implant placement with dentin-derived membrane and allograft in mandibular molar area
immediate implant with extended platelet rich fibrin membrane
immediate implant with extended platelet rich fibrin membrane and allograft in mandibular molar area
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Non-restorable mandibular molar tooth that needs dental extraction \& guided bone regeneration for immediate implant placement.
* Acceptable inter-arch space for the future prosthesis.
* Patient medically free from systemic diseases that absolutely contraindicate implant surgery.
* Cooperative patient with high motivation and acceptable oral hygiene.
* Free from history of bruxism / parafunctional habits.
Exclusion Criteria
* Smokers.
* Pregnancy.
* Uncooperative patients.
* Patient had undergone in the past 12 months radiation therapy to the head and neck area.
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mansoura University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Heba Elsheikh
Al Mansurah, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A06030240S
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.